Access 2.8M+ Filings Sign Up Free
Basilea Pharmaceutica AG Logo

Basilea Pharmaceutica AG | BSLN - Profile, Filings, Stock Info & Investor Relations Data

Basilea Pharmaceutica AG | BSLN
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Pharmaceuticals
Country
Switzerland
Founded
2000
Basilea Pharmaceutica AG (BSLN)

Company Profile

Website
Investor Relations

About Basilea Pharmaceutica AG

Basilea is a revenue-generating, commercial-stage Swiss biopharmaceutical company. Our activities are focused in the areas of hospital antibiotics, hospital antifungals and cancer treatments. Our portfolio comprises of two marketed anti-infective brands (Cresemba® and Zevtera®) and three oncology drug candidates in clinical development. We are building on our potential for sustainable growth and valuation generation, based on increasing revenues and selective investments into internal and external innovation. Basilea was founded in 2000 and is located in the life sciences hub of the Basel area. Basilea has about 150 employees. Since 2004, Basilea is listed on the SIX Swiss Stock Exchange with the ticker symbol BSLN.

Employees

150

Market Presence

Worldwide

Headquarters

Henric Petri-Strasse 35
4051, Basel
Switzerland

Basilea Pharmaceutica AG (BSLN)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Basilea Pharmaceutica AG (BSLN)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↓
N/A (Executive member)
Sell CHF 57,396.20 CHF 41.93 23.04.25
↓
N/A (Non-Executive member)
Sell CHF 30,331.00 CHF 41.55 23.04.25
↓
N/A (Executive member)
Sell CHF 173,479.91 CHF 41.26 17.04.25
↓
N/A (Executive member)
Sell CHF 118,568.67 CHF 41.26 17.04.25
↓
N/A (Executive member)
Sell CHF 41,255.63 CHF 41.26 17.04.25
↓
N/A (Executive member)
Sell CHF 22,500.00 CHF 45.00 28.10.24
↓
N/A (Executive member)
Sell CHF 79,966.26 CHF 41.01 25.04.24
↓
N/A (Executive member)
Sell CHF 23,128.70 CHF 41.01 24.04.24

Basilea Pharmaceutica AG (BSLN)
Stock & Investor Information

ISINs

CH0011432447
CH0554992062

LEI

391200TTZP8EIPSJ5J20

Stock Exchange Listings

SIX Swiss Exchange

Industry Classification

Sector
Health Care
Industry
Pharmaceuticals